Your browser doesn't support javascript.
loading
Integrated population pharmacokinetics of etirinotecan pegol and its four metabolites in cancer patients with solid tumors.
Sy, Sherwin K B; Chia, Yen Lin; Gordi, Toufigh; Hoch, Ute; Eldon, Michael A.
Affiliation
  • Sy SKB; Department of Clinical Pharmacology, Nektar Therapeutics, 455 Mission Bay Blvd South, San Francisco, CA, 94158, USA.
  • Chia YL; Department of Clinical Pharmacology, Nektar Therapeutics, 455 Mission Bay Blvd South, San Francisco, CA, 94158, USA.
  • Gordi T; Department of Clinical Pharmacology, Nektar Therapeutics, 455 Mission Bay Blvd South, San Francisco, CA, 94158, USA.
  • Hoch U; Department of Clinical Pharmacology, Nektar Therapeutics, 455 Mission Bay Blvd South, San Francisco, CA, 94158, USA.
  • Eldon MA; Department of Clinical Pharmacology, Nektar Therapeutics, 455 Mission Bay Blvd South, San Francisco, CA, 94158, USA. meldon@nektar.com.
Cancer Chemother Pharmacol ; 81(5): 897-909, 2018 05.
Article in En | MEDLINE | ID: mdl-29564497

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyethylene Glycols / Heterocyclic Compounds, 4 or More Rings / Models, Biological / Neoplasms / Antineoplastic Agents Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyethylene Glycols / Heterocyclic Compounds, 4 or More Rings / Models, Biological / Neoplasms / Antineoplastic Agents Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2018 Document type: Article